Focusfreda successfully obtained the national invention patent and moved into a new field of health industry

Recently, Focusfreda successfully authorized a new national patented technology called “A Preparation Method and Application of Astaxanthin Hyaluronic Acid Ester and Micelles”. The successful authorization of this patent is recognition of our continuous innovation and R&D capabilities, and also marks another important step for us in the big health industry.

There are currently many studies trying to combine hyaluronic acid with astaxanthin in order to improve the low bioavailability and instability of astaxanthin and broaden the application fields of hyaluronic acid so that it is no longer limited to cosmetics. “A preparation method and application of astaxanthin hyaluronic acid ester and micelles” provides a simple and effective preparation method of astaxanthin hyaluronic acid composition. The prepared product has good water solubility and high stability. , strong skin penetration, good antioxidant effect, and amphipathic. The composition itself and the micelles prepared based on it have huge application potential.

Over the years, Focus Freda has always been committed to the research and development of innovative technologies, constantly breaking through and forging ahead. At present, we have obtained more than 70 patents authorized by the State Intellectual Property Office through application. In the future, Focus Freda will continue to increase investment in research and development, continue to innovate, and create greater industrial value for our customers.